Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.

[1]  C. Oudin,et al.  Lethal ALAS2 mutation in males X‐linked sideroblastic anaemia , 2017, British journal of haematology.

[2]  Szymon J. Ciesielski,et al.  Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9. , 2015, Blood.

[3]  J. Wood.  Estimating tissue iron burden: current status and future prospects , 2015, British journal of haematology.

[4]  V. Salpietro,et al.  Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment , 2015, European journal of haematology.

[5]  Jacob C. Ulirsch,et al.  X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. , 2015, The Journal of clinical investigation.

[6]  S. Perrotta,et al.  Endocrine function and bone disease during long‐term chelation therapy with deferasirox in patients with β‐thalassemia major , 2014, American journal of hematology.

[7]  S. Reeder,et al.  Quantification of liver iron with MRI: State of the art and remaining challenges , 2014, Journal of magnetic resonance imaging : JMRI.

[8]  Erin K. Kennedy,et al.  Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). , 2014, Blood.

[9]  M. Fleming,et al.  Sideroblastic anemia: diagnosis and management. , 2014, Hematology/oncology clinics of North America.

[10]  D. Swinkels,et al.  Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis. , 2014, Blood.

[11]  Yali Zhou,et al.  Splenectomy improves anaemia but does not reduce iron burden in patients with haemoglobin H Constant Spring disease. , 2014, Blood transfusion = Trasfusione del sangue.

[12]  E. Tolosano,et al.  Heme and erythropoieis: more than a structural role , 2014, Haematologica.

[13]  M. Lombardi,et al.  Myocardial iron overload in thalassaemia major. How early to check? , 2014, British journal of haematology.

[14]  A. Filosa,et al.  Effect of splenectomy on iron balance in patients with β‐thalassemia major: a long‐term follow‐up , 2013, European journal of haematology.

[15]  M. Cappellini,et al.  Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. , 2012, Blood reviews.

[16]  P. Brissot,et al.  Non-transferrin bound iron: a key role in iron overload and iron toxicity. , 2012, Biochimica et biophysica acta.

[17]  M. Fleming.  Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation. , 2011, Hematology. American Society of Hematology. Education Program.

[18]  J. Barton,et al.  Sideroblastic anemia, iron overload, and ALAS2 R452S in African‐American males: Phenotype and genotype features of five unrelated patients , 2011, American journal of hematology.

[19]  D. Swinkels,et al.  Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemia , 2011, International journal of hematology.

[20]  H. Heimpel,et al.  Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations , 2011, Human mutation.

[21]  J. Maciejewski,et al.  Postsplenectomy thromboembolic disease in congenital sideroblastic anaemia , 2010, BMJ Case Reports.

[22]  K. Furuyama,et al.  Hereditary sideroblastic anemia: pathophysiology and gene mutations , 2010, International journal of hematology.

[23]  E. Neufeld,et al.  Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations , 2010, Pediatric blood & cancer.

[24]  G. Buchanan,et al.  Vascular complications after splenectomy for hematologic disorders. , 2009, Blood.

[25]  B. Mueller,et al.  Oral iron chelation and the treatment of iron overload in a pediatric hematology center , 2009, Pediatric blood & cancer.

[26]  C. Beaumont,et al.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis , 2009, Haematologica.

[27]  M. Cappellini,et al.  High nontransferrin bound iron levels and heart disease in thalassemia major , 2009, American journal of hematology.

[28]  C. Camaschella.  Recent advances in the understanding of inherited sideroblastic anaemia , 2008, British journal of haematology.

[29]  Maria Domenica Cappellini,et al.  Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders , 2008, Haematologica.

[30]  E. Glimm,et al.  Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. , 2008, Blood.

[31]  L. Malcovati.  Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. , 2007, Leukemia research.

[32]  B. Specker,et al.  Quantitative bone analysis in children: current methods and recommendations. , 2006, The Journal of pediatrics.

[33]  E. Shpall,et al.  Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia , 2003, Bone Marrow Transplantation.

[34]  J. Porter.  Practical management of iron overload , 2001, British journal of haematology.

[35]  J. S. San Miguel,et al.  Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia , 2000, British journal of haematology.

[36]  M. Cazzola,et al.  Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. , 1999, Blood.

[37]  B. Binder,et al.  Congenital sideroblastic anemia successfully treated by allogeneic bone marrow transplantation. , 1992, Bone marrow transplantation.

[38]  R. P. Spencer,et al.  Sideroblastic anemia with splenic abscess and fatal thromboemboli after splenectomy. , 1975, Annals of internal medicine.

[39]  J. White,et al.  Globin Synthesis in Sideroblastic Anaemia , 1973 .

[40]  J. Dacie,et al.  Persistent Post‐Splenectomy Thrombocytosis and Thrombo‐embolism: A Consequence of Continuing Anaemia , 1966, British journal of haematology.

[41]  M. Angastiniotis,et al.  Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines , 2013, Indian journal of endocrinology and metabolism.

[42]  V. Gilsanz.  Bone density in children: a review of the available techniques and indications. , 1998, European journal of radiology.